Clinical trial

Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome

NCT06410352

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-03-01

PhasePHASE4

Study timeline

Study start (actual)2024-03-01Date precision: day

Registry last updated2025-11-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metabolic Syndromeunresolved

Interventions

Semaglutide, EmpagliflozinDRUG

Minigastric bypassPROCEDURE

Analimentary detoxicationDIETARY_SUPPLEMENT

Ramadan fast's weight lossBEHAVIORAL

Sponsors & collaborators

University Medical Center, Kazakhstanlead sponsor

Nazarbayev University School of Medicinecollaborator

Nazarbayev Universitycollaborator

Astana Medical Universitycollaborator

Public Association "Eurasian Society of Personalized Medicine"collaborator

Ministry of Science and Higher Education of the Republic of Kazakhstancollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06410352 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.